Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: There is currently no cure for Becker muscular dystrophy (BMD), so treatment focuses on managing symptoms, maintaining mobility, and preventing complications through a multidisciplinary approach. Standard care includes physical therapy, cardiac monitoring, and the use of corticosteroids to preserve muscle strength and delay the progression of Becker muscular dystrophy. What are the first-line treatments for Becker muscular dystrophy? Because Becker muscular dystrophy is caused by a partial deficiency of the protein dystrophin, the primary goal of medical management is to maintain muscle function for as long as possible.
1 people with Becker muscular dystrophy have shared their first-person experience on this question at DiseaseMaps.
TL;DR: There is currently no cure for Becker muscular dystrophy (BMD), so treatment focuses on managing symptoms, maintaining mobility, and preventing complications through a multidisciplinary approach. Standard care includes physical therapy, cardiac monitoring, and the use of corticosteroids to preserve muscle strength and delay the progression of Becker muscular dystrophy.
Because Becker muscular dystrophy is caused by a partial deficiency of the protein dystrophin, the primary goal of medical management is to maintain muscle function for as long as possible. Many specialists prescribe corticosteroids, such as prednisone or deflazacort (Emflaza), to help preserve muscle strength and delay the onset of severe weakness. It is important to note that treatment protocols for Becker muscular dystrophy must be highly personalized by a neuromuscular specialist, as side effects—such as weight gain, bone density loss, and behavioral changes—require careful monitoring.
Non-pharmacological interventions are the cornerstone of care for individuals living with Becker muscular dystrophy. Because the disease progresses at a variable rate, these therapies are adjusted as the patient's physical needs evolve. Key management strategies include:
Managing Becker muscular dystrophy requires a multidisciplinary team to address the systemic effects of the condition. A comprehensive care team typically includes:
Medical researchers are actively investigating novel therapies to address the underlying cause of Becker muscular dystrophy. Clinical trials are currently exploring gene-directed therapies, such as exon skipping and gene replacement strategies, aimed at increasing dystrophin production. While some of these therapies have shown promise in related muscular dystrophies, they remain in various stages of clinical research for Becker muscular dystrophy specifically. Patients are encouraged to consult clinical trial registries to see if they meet the criteria for ongoing research studies.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.